Dean J Kereiakes

Dean J Kereiakes

UNVERIFIED PROFILE

Are you Dean J Kereiakes?   Register this Author

Register author
Dean J Kereiakes

Dean J Kereiakes

Publications by authors named "Dean J Kereiakes"

Are you Dean J Kereiakes?   Register this Author

100Publications

2962Reads

20Profile Views

Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.

Heart 2019 Nov 5;105(21):1616-1621. Epub 2019 Jun 5.

Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2019-314879DOI Listing
November 2019

Response by Riley et al to Letter Regarding Article, "More Data Than Options for the 'No-Option' Refractory Angina Patient in the United States".

Circ Res 2019 Oct 10;125(9):e42. Epub 2019 Oct 10.

The Christ Hospital Heart and Vascular Center/The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.119.315845DOI Listing
October 2019

The clinical characteristics of coronary artery fistula anomalies in children and adults: A 24-year experience.

Congenit Heart Dis 2019 Sep 28;14(5):772-777. Epub 2019 May 28.

Department of Cardiology, Tam Duc Heart Hospital, Ho Chi Minh City, Vietnam.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/chd.12781
Publisher Site
http://dx.doi.org/10.1111/chd.12781DOI Listing
September 2019

Impact of High Baseline Left Ventricular Filling Pressure on Transcatheter Aortic Valve Replacement Outcomes in Patients with Significant Mitral Annular Calcification.

J Am Soc Echocardiogr 2019 Sep 2;32(9):1067-1074.e1. Epub 2019 Jul 2.

The Heart and Vascular Center and The Lindner Research Center, The Christ Hospital, Cincinnati, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2019.05.003DOI Listing
September 2019

Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.

Catheter Cardiovasc Interv 2019 Jun 4;93(7):1228-1235. Epub 2018 Nov 4.

Department of Medicine, Cardiology Division, Atlanta VA Medical Center, Emory University School of Medicine, Decatur, Georgia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.27935
Publisher Site
http://dx.doi.org/10.1002/ccd.27935DOI Listing
June 2019

Intravascular lithotripsy-assisted Impella insertion: A case report.

Catheter Cardiovasc Interv 2019 Jun 27;93(7):1317-1319. Epub 2019 Feb 27.

Department of Ohio Heart and Vascular, The Christ Hospital and Lindner Center for Research and Education, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28168DOI Listing
June 2019

More Data Than Options for the "No-Option" Refractory Angina Patient in the United States.

Circ Res 2019 Jun 6;124(12):1689-1691. Epub 2019 Jun 6.

From the Christ Hospital Heart and Vascular Center / The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.119.315138DOI Listing
June 2019

ABSORB IV: will the low rate of scaffold thrombosis persist? - Authors' reply.

Lancet 2019 06;393(10189):2392-2393

Carl and Edyth Lindner Research Center at The Christ Hospital, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)30687-7DOI Listing
June 2019

Changes in mechanical dyssynchrony in severe aortic stenosis patients undergoing transcatheter aortic valve replacement.

Echocardiography 2019 02 9;36(2):243-248. Epub 2019 Jan 9.

The Christ Hospital Heart and Vascular Center, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.14237DOI Listing
February 2019

The Myths of the Bare-Metal Stent.

Authors:
Dean J Kereiakes

JAMA Cardiol 2018 11;3(11):1039-1040

The Christ Hospital Heart and Vascular Center, The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2018.3573DOI Listing
November 2018

Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women.

Circ Cardiovasc Interv 2018 08;11(8):e005308

Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (N.C.B., L.M.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.11
Publisher Site
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005308DOI Listing
August 2018

No Risk, No Reward.

Circ Res 2018 08;123(5):521-523

From the Cedars-Sinai Smidt Heart Institute, Los Angeles, CA (J.M.T., T.D.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.118.313593DOI Listing
August 2018

Healing by design: in vivo insights following contemporary coronary stent deployment.

Authors:
Dean J Kereiakes

Eur Heart J 2018 07;39(26):2457-2459

The Christ Hospital Heart and Vascular Center/The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy338DOI Listing
July 2018

Evolution of the SYNERGY bioresorbable polymer metallic coronary stent.

Future Cardiol 2018 07 21;14(4):307-317. Epub 2018 Jun 21.

The Christ Hospital Heart & Vascular Center/The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital, 2123 Auburn Avenue, Suite 424, Cincinnati 45219, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fca-2018-0040DOI Listing
July 2018

Is two better than one? Re-evaluating the surgical approval process for TAVR.

Catheter Cardiovasc Interv 2018 Jul 18. Epub 2018 Jul 18.

The Christ Hospital Heart and Vascular Center/The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27666DOI Listing
July 2018

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

J Am Coll Cardiol 2017 Dec 31;70(23):2852-2862. Epub 2017 Oct 31.

New York Presbyterian Hospital, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.10.010DOI Listing
December 2017

Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.

J Am Coll Cardiol 2017 Dec 31;70(23):2863-2874. Epub 2017 Oct 31.

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.09.1106DOI Listing
December 2017

Exercise-induced saphenous vein graft spasm prevented by stenting.

Catheter Cardiovasc Interv 2017 Nov 17;90(6):937-944. Epub 2017 Mar 17.

Baptist Health Lexington, Lexington, Kentucky.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27026DOI Listing
November 2017

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

J Am Coll Cardiol 2017 Oct;70(18):2213-2223

Baim Institute for Clinical Research, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.09.011DOI Listing
October 2017

Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.

JACC Cardiovasc Interv 2017 09;10(18):1809-1815

Interventional Cardiology, A.O., Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2017.06.067DOI Listing
September 2017

2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy.

Lancet 2017 Aug 18;390(10096):760-772. Epub 2017 Jul 18.

New York Presbyterian Hospital, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(17)31470-8DOI Listing
August 2017

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia.

Coron Artery Dis 2017 May;28(3):190-197

aDepartment of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands bThe Christ Hospital, Heart and Vascular Center/The Lindner Research Center, Cincinnati, Ohio cHarvard Clinical Research Institute, Boston, Massachusetts dLouisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville, Kentucky eSanofi, Bridgewater, New Jersey fRegeneron Pharmaceuticals Inc., Tarrytown, New York, USA gBiostatistics and Programming, Sanofi, Chilly-Mazarin hPoint Médical, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCA.0000000000000438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400401PMC
May 2017

Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).

Circulation 2017 May 22;135(18):1720-1732. Epub 2017 Feb 22.

From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and Vascular Center and Lindner Center for Research and Education, Cincinnati, OH (D.J.K.); and Beth Israel Deaconess Medical Center, Boston, MA (D.E.C., R.W.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024835DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469374PMC
May 2017

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.

JAMA Cardiol 2017 05;2(5):478-487

Harvard Medical School, Boston, Massachusetts 3Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 5Baim Institute for Clinical Research, Boston, Massachusetts 14Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2017.0063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814981PMC
May 2017

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.

JACC Cardiovasc Interv 2017 05;10(9):942-954

Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798173032
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2017.02.013DOI Listing
May 2017

The TWENTE Trial in Perspective: Stents and Stent Trials in Evolution.

Authors:
Dean J Kereiakes

JAMA Cardiol 2017 03;2(3):235-237

The Christ Hospital Heart and Vascular Center, Cincinnati, Ohio2The Lindner Center for Research and Education, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2016.5208DOI Listing
March 2017

Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?

Coron Artery Dis 2017 Jan;28(1):77-89

aHonorHealth and the Scottsdale-Lincoln Health Network bHonorHealth, Scottsdale Shea Medical Center, Scottsdale, Arizona cSt Vincent Heart Center, Indianapolis, Indiana dAbbott Vascular, Santa Clara, California eThe Christ Hospital, Heart and Vascular Center and The Lindner Research Center, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCA.0000000000000414DOI Listing
January 2017

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Circ Res 2017 Jan 7;120(2):324-331. Epub 2016 Nov 7.

From the Emory Clinical Cardiovascular Research Institute, Cardiology Division, Emory University School of Medicine, Atlanta, GA (A.A.Q., J.P.); Athens Regional Cardiology, GA (J.P.); Division of Cardiology, Huntsville Hospital, Huntsville, AL (A.V.); The Christ Hospital Heart and Vascular Center, Cincinnati, OH (D.J.K.); Rutgers University, New Jersey Medical School, Newark (M.K.); Division of Cardiology, Rush University Medical Center, Chicago, IL (G.L.S.); Department of Medicine, Division of Cardiology, University of Kentucky, Lexington (A.A.-L.); Emory St. Joseph's Hospital, Atlanta, GA (S.F.); Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA (T.D.H.); Scripps Health, La Jolla, CA (R.A.S.); Heart Sciences Center, Gilbert, AZ (N.D.); University of Pittsburgh Medical Center, PA (C.T.); Bluhm Cardiovascular Institute Northwestern Memorial Hospital, Chicago, IL (C.J.D.); Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (G.W.B.); Cardiovascular Medicine, University of Southern California, Los Angeles, CA (D.M.S.); Westchester Heart and Vascular, Westchester Medical Center, Valhalla, NY (M.C.); Caladrius Biosciences Inc, Basking Ridge, NJ (T.M., P.H., A.M.K., V.D., A.C., C.J., R.A.P., R.L.S., D.J.M., A.P., D.W.L.); and PCT, LLC, A Caladrius Company, Allendale, NJ (R.A.P.).

View Article

Download full-text PDF

Source
https://professional.heart.org/idc/groups/ahamah-public/@wcm
Web Search
http://circres.ahajournals.org/content/early/2016/11/07/CIRC
Web Search
http://dx.doi.org/10.1161/CIRCRESAHA.115.308165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903285PMC
January 2017

Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy.

JACC Cardiovasc Interv 2017 01 21;10(1):42-49. Epub 2016 Dec 21.

New York Presbyterian Hospital, Columbia University Medical Center, New York, New York; Cardiovascular Research Foundation, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2016.10.019DOI Listing
January 2017

Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.

Catheter Cardiovasc Interv 2016 Nov;88(S1):21-30

The Christ Hospital Heart and Vascular Center, The Lindner Research Center, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26810DOI Listing
November 2016

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.

Circulation 2016 Oct 30;134(14):989-998. Epub 2016 Aug 30.

From Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, MA (C.D.R., L.M.); Harvard Clinical Research Institute, Boston, MA (R.W.Y., D.E.C., W.-H.H., L.M.); Harvard Medical School, Boston, MA (R.W.Y., L.M.); Division of Cardiology, University of Pennsylvania Medical Center, Philadelphia (A.N.); Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y., D.E.C.); Department of Biostatistics, Boston University School of Public Heath, MA (J.M.M.); The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, OH (D.J.K.); Université Paris-Diderot, INSERM U-1148, Hôpital Bichat, Département Hospitalo-Universitaire Fibrosis, Inflammation, and Remodeling, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.); and National Heart and Lung Institute, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, Imperial College, London, UK (P.G.S.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421387PMC
October 2016

MRI-based evidence for myocardial involvement in women with hypereosinophilic syndrome.

Magn Reson Med Sci 2015 ;14(2):107-14

Department of Medicine, Jagiellonian University Medical College ul. Skawinska 8, 31–066 Kraków, Poland; Department of Radiology and Imaging Diagnostics, John Paul II Hospital, Kraków, Poland; Center for Heart Disease, Clinical Military Hospital, Wrocław, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2463/mrms.2013-0133DOI Listing
August 2016

One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.

Circulation 2016 Jul;134(2):130-40

From Perelman School of Medicine at the University of Pennsylvania, Philadelphia (H.C.H., W.Y.S., S.A., N.D.); Emory University, Atlanta, GA (V.H.T., V.B.); Columbia University Medical Center, New York, NY (S.K.K., R.T.H., M.B.L.); Cedars-Sinai Medical Center, Los Angeles, CA (R.R.M.); University of Virginia, Charlottesville (S.L.); Northwestern University, Chicago, IL (S.C.M.); The Christ Hospital, Cincinnati, OH (D.J.K.); Ochsner Clinic, New Orleans, LA (S.R.); Mayo Clinic, Rochester, MN (K.L.G.); Cleveland Clinic, OH (S.K.); Department of Medicine, Laval University, Quebec, Canada (P.P.); Medstar Health Research Institute and Georgetown University, Washington, DC (N.J.W.); St. Paul's Hospital, Vancouver, BC, Canada (J.L., J.G.W.); Intermountain Medical Center, Salt Lake City, UT (B.K.W.); and Baylor Scott and White Health, Plano, TX (M.J.M.); and the PARTNER Trial Publication Office, New York, NY (H.C.H., V.H.T., S.K.K., R.R.M., D.J.K., S.K., V.B., R.T.H., P.P., N.J.W., J.L., J.G.W., M.J.M., M.B.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022797DOI Listing
July 2016

Bioresorbable Vascular Scaffolds for Coronary Revascularization.

Circulation 2016 Jul;134(2):168-82

From The Christ Hospital, Heart and Vascular Center, Lindner Research Center, Cincinnati, OH (D.J.K.); Thorax Centre, Erasmus MC, Rotterdam, The Netherlands (Y.O.); International Centre for Cardiovascular Health, Imperial College, London, UK (P.W.S.); and New York Presbyterian Hospital, Columbia University Medical Center, and the Cardiovascular Research Foundation, New York (G.W.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021539DOI Listing
July 2016

Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.

Circulation 2016 May 18;133(18):1772-82. Epub 2016 Mar 18.

From Monash Heart and Monash University, Melbourne, Australia (I.T.M., W.-H.H.); Montreal Heart Institute, Université de Montréal, Québec, Canada (J.-F.T.); The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, OH (D.J.K.); Beth Israel Deaconess Medical Center, Boston, MA (D.E.C.); Harvard Clinical Research Institute, Boston, MA (D.E.C., R.W.Y., J.M.M., L.M.); Harvard Medical School, Boston, MA (D.E.C., R.W.Y., L.M.); The Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.); Lenox Hill Hospital, New York, NY (K.N.G.); Stanford University, Stanford, CA (D.P.L.); Université Paris-Diderot, INSERM U-1148, Hôpital Bichat, Département Hospitalo-Universitaire Fibrosis, Inflammation, and Remodeling, Assistance Publique-Hôpitaux de Paris - all in Paris, National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.); Henry Ford Medical Group, Detroit, MI (W.D.W.); Mayo Clinic, Rochester, MN (D.R.H.); Institute for Health Policy Studies, University of California, San Francisco (R.G.B.); Jan Pawel II Hospital Krakow, Poland (J.T.); Boston University School of Public Health, Boston, MA (J.M.M.); and Brigham and Women's Hospital, Boston, MA (L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016783DOI Listing
May 2016

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction.

J Am Coll Cardiol 2016 May 1;67(21):2492-502. Epub 2016 Apr 1.

Harvard Medical School, Boston, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts; Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.03.485DOI Listing
May 2016

Novel 3-Dimensional Vessel and Scaffold Reconstruction Methodology for the Assessment of Strut-Level Wall Shear Stress After Deployment of Bioresorbable Vascular Scaffolds From the ABSORB III Imaging Substudy.

JACC Cardiovasc Interv 2016 Mar;9(5):501-3

Andreas Gruentzig Cardiovascular Center, Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; Emory Cardiovascular Imaging & Biomechanics Core Laboratory, Emory University School of Medicine, Atlanta, Georgia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2016.01.008DOI Listing
March 2016

Causes of late mortality with dual antiplatelet therapy after coronary stents.

Eur Heart J 2016 Jan 18;37(4):378-85. Epub 2015 Nov 18.

The Christ Hospital Heart and Vascular Center, The Lindner Center for Research and Education, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehv614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751218PMC
January 2016

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.

JACC Cardiovasc Interv 2016 Jan;9(2):138-47

Harvard Medical School, Boston, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2015.10.001DOI Listing
January 2016

Angiographic result of index PCI determines the presence of right ventricular infarction in patients with acute inferior myocardial infarction.

Int J Cardiovasc Imaging 2015 Dec 25;31(8):1591-601. Epub 2015 Jul 25.

Department of Interventional Cardiology, John Paul II Hospital, Jagiellonian University Medical College, Prądnicka 80, 31-202, Kraków, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10554-015-0717-8DOI Listing
December 2015

The PCSK9 Inhibitors: A Novel Therapeutic Target Enters Clinical Practice.

Am Health Drug Benefits 2015 Dec;8(9):483-9

Dr Kereiakes is Medical Director, the Christ Hospital Heart and Vascular Center, and the Carl and Edyth Lindner Center for Research and Education at the Christ Hospital, Cincinnati, OH, and Professor of Clinical Medicine, Ohio State University, Columbus.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719137PMC
December 2015

Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results.

Catheter Cardiovasc Interv 2015 Nov 25;86(6):994-1001. Epub 2015 Feb 25.

Interventional Cardiology, Boston Scientific Corporation, Marlborough, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25877DOI Listing
November 2015

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

N Engl J Med 2015 Nov 12;373(20):1905-15. Epub 2015 Oct 12.

From Cleveland Clinic, Cleveland (S.G.E.), the Christ Hospital, Heart and Vascular Center, Lindner Research Center, Cincinnati (D.J.K.), and Mercy St. Vincent's Medical Center, Toledo (A. Kini) - all in Ohio; Wellmont Holston Valley Medical Center, Kingsport, TN (D.C.M.); St. Joseph's Hospital Health Center, Liverpool, NY (R.P.C.); Scottsdale Healthcare, Scottsdale, AZ (D.G.R.); Scripps Clinic, La Jolla (P.S.T.), and Abbott Vascular, Santa Clara (R.M., Z.Z., C.S.) - both in California; Baptist Medical Center, Jacksonville, FL (M.R.L.); Mount Sinai Medical Center (A. Kabour), Columbia University Medical Center (S.O.M., G.W.S.), and the Cardiovascular Research Foundation (G.W.S.) - all in New York; and the Beth Israel Deaconess Medical Center, Boston (J.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509038DOI Listing
November 2015

Reply: Analysis of Dual Antiplatelet Therapy.

J Am Coll Cardiol 2015 Nov;66(18):2056

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.08.855DOI Listing
November 2015

The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug-eluting stent: Current concepts and overview of clinical evidence.

Catheter Cardiovasc Interv 2015 Oct;86(4):664-77

Medical Director of The Christ Hospital Heart and Vascular Center, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26172DOI Listing
October 2015

Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.

Am Heart J 2015 Oct 26;170(4):641-651.e3. Epub 2015 Jul 26.

Columbia University Medical Center, New York Presbyterian Hospital and The Cardiovascular Research Foundation, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2015.07.013DOI Listing
October 2015

Mortality risk with dual antiplatelet therapy?

Lancet 2015 Oct;386(10003):1533-4

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Harvard Clinical Research Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00486-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671290PMC
October 2015

Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.

Clin J Am Soc Nephrol 2015 Sep 16;10(9):1519-24. Epub 2015 Jul 16.

Department of Medicine, University of Vermont Medical Center, Burlington, Vermont;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.05370514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559510PMC
September 2015

Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia.

Am J Cardiol 2015 May 12;115(9):1194-9. Epub 2015 Feb 12.

Columbia University Medical Center/New York-Presbyterian Hospital, New York, New York; Cardiovascular Research Foundation, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.01.556DOI Listing
May 2015

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

J Am Coll Cardiol 2015 May 15;65(20):2211-21. Epub 2015 Mar 15.

Harvard Clinical Research Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678101PMC
May 2015

Dual antiplatelet therapy duration and mortality - Authors' reply.

Lancet 2015 May;385(9983):2149-50

Harvard Clinical Research Institute, Boston, MA, USA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)61019-4DOI Listing
May 2015

The potential role of anti-PCSK9 monoclonal antibodies in the management of hypercholesterolemia.

Rev Cardiovasc Med 2014 ;15(4):290-307; quiz 308-9

The Christ Hospital Heart and Vascular Center, The Lindner Research Center, Cincinnati, OH.

View Article

Download full-text PDF

Source
April 2015

Duration of dual antiplatelet therapy after drug-eluting stents.

N Engl J Med 2015 04;372(14):1373-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1501195DOI Listing
April 2015

Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort.

Circ Cardiovasc Interv 2015 Apr;8(4)

From the Washington University School of Medicine, St. Louis, MO (B.R.L., H.S.M., A.Z.); Cleveland Clinic Foundation, OH (W.A.J., E.M.T., L.G.S.); Emory University School of Medicine, Atlanta, GA (S.L., V.H.T., V.B.); Baylor Scott and White Health, Plano, TX (M.J.M.); Mayo Clinic, Rochester, MN (R.M.S.); The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH (D.J.K.); Intermountain Heart Center, Murray, UT (B.W.); Stanford University School of Medicine, CA (D.C.M.); Cardiovascular Research Foundation, New York, NY (K.X., M.B.L.); and Columbia University Medical Center/New York Presbyterian Hospital (D.D., M.B.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.114.002073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438083PMC
April 2015

Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.

Circ Cardiovasc Interv 2015 Apr;8(4)

From the Heart and Vascular Center/The Lindner Research Center, Christ Hospital, Cincinnati, OH (D.J.K., I.J.S.); Department of Medicine, MonashHEART, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia (I.T.M.); Department of Cardiology, Bern University Hospital, Bern, Switzerland (S.W.); Department of Invasive Cardiology, Wake Medical Center, Raleigh, NC (R.L.J.); Department of Medicine, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada (S.R.M.); Invasive/Interventional Cardiology, Mediquest Research at Munroe Regional Medical Center, Ocala, FL (R.L.F.); Interventional Cardiology, Morton Plant Mease Healthcare System, Clearwater, FL (B.S.); Department of Cardiology, University Hospital Leuven, Leuven, Belgium (C.D.); Research and Education, Aspirus Heart and Vascular Institute-Research and Education, Wausau, WI (T.G.); Division of Cardiology and Catherization Laboratories Heart Center, Shonan Kamakura General Hospital, Kanagawa, Japan (S.S.); Department of Cardiovascular Medicine, Kyoto University Hospital, Kyoto, Japan (T.K.); and Clinical Sciences, Boston Scientific Corporation, Marlborough, MA (T.C., D.J.A., K.D.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.114.002372DOI Listing
April 2015

Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy.

JACC Cardiovasc Interv 2015 Mar 18;8(3):404-410. Epub 2015 Feb 18.

Division of Cardiology, University of Vermont College of Medicine, Burlington, Vermont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2014.10.017DOI Listing
March 2015

Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected].

J Am Coll Cardiol 2015 Mar;65(8):787-790

The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689133PMC
March 2015

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Lancet 2015 Feb 16;385(9970):792-8. Epub 2014 Nov 16.

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Harvard Clinical Research Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01406736146205
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(14)62052-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386690PMC
February 2015

Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Circ Cardiovasc Qual Outcomes 2015 Jan 16;8(1):96-102. Epub 2014 Nov 16.

From the Cardiology Division, Department of Medicine, Massachusetts General Hospital (R.W.Y), Department of Health Care Policy (Biostatistics) (S.-L.T.N.), and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital (L.M.), Harvard Medical School, Boston, MA (R.W.Y., S.-L.T.N., L.M.); Harvard Clinical Research Institute, Boston, MA (R.W.Y., P.D.S., L.M.); Cardiology Division, Department of Medicine, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD (M.J.C.); Department of Biostatistics, Harvard University School of Public Health, Boston, MA (S.-L.T.N.); The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH (D.J.K.); Cardiology Division, Mayo Clinic, Rochester, MN (D.R.H., Jr); Philip R. Lee Institute for Health Policy Studies, Department of Medicine, University of California, San Francisco (R.G.B.); Heart and Vascular Institute, Henry Ford Health System, Detroit, MI (W.D.W.); Cardiology Division, Denver VA Medical Center/Veterans Health Administration, CO (J.S.R.); and Duke Clinical Research Institute, Durham, NC (M.T.R., S.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.114.001239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303486PMC
January 2015

Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement.

Circulation 2015 Jan 16;131(1):62-73. Epub 2014 Nov 16.

From Lenox Hill Hospital, New York, NY (K.N.G.); Henry Ford Heart and Vascular Institute, Henry Ford Health System, Detroit, MI (W.D.W.); Kootenai Medical Center, Coeur d'Alene, ID (R.G.J.); Lakeland Hospitals at St. Joseph, St. Joseph, MI (T.K.P.); Brigham and Women's Hospital, Boston, MA (L.M.); The Christ Hospital Heart and Vascular Center/The Lindner Research Center Heart & Vascular Center, Cincinnati, OH (D.J.K.); Eli Lilly and Co, Indianapolis, IN (K.J.W.); Boston Scientific Corporation, Marlborough, MA (T.C., D.J.A.); and Stanford University Medical Center, Stanford, CA (D.P.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013570DOI Listing
January 2015

Correction to "The Potential Role of Anti-PCSK9 Monoclonal Antibodies in the Management of Hypercholesterolemia".

Rev Cardiovasc Med 2015;16(1):94-309

The David Geffen School of Medicine at UCLA and Cedars-Sinai Medical Center, Los Angeles, CA; Westside Medical Associates of Los Angeles, Beverly Hills, CA; The Christ Hospital Heart and Vascular Center, The Lindner Research Center, Cincinnati, OH.

View Article

Download full-text PDF

Source
January 2015

Volume driven performance metrics in STEMI care: does practice make perfect?

Catheter Cardiovasc Interv 2014 Nov;84(6):948-9

Division of Cardiology, Cedars-Sinai Heart Institute, 127 S San Vicente Blvd, Suite A3600, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25677DOI Listing
November 2014